News

Sep 19, 2023

I've Got My Eye On Ionis Pharmaceuticals for Higher Highs

Ionis Pharmaceuticals, Inc. IONS is a biotechnology company that specializes in

Ionis Pharmaceuticals, Inc. IONS is a biotechnology company that specializes in discovering and developing RNA-targeted therapeutics. I have a BA degree so this science is way above my pay grade. The stock's charts are right in my wheelhouse, though.

Let's check out IONS.

In the daily bar chart of IONS, below, I can see that the shares have broken their downward path and launched an uptrend. The shares are now trading above the rising 50-day moving average line and above the slightly declining 200-day line.

It looks like the trading volume has increased since the middle of February. The On-Balance-Volume (OBV) line has risen from the middle of March, telling me that buyers of IONS have been more aggressive than sellers. The Moving Average Convergence Divergence (MACD) oscillator is bullish.

Employees of TheStreet are prohibited from trading individual securities.

This week was good for the bulls, but we have no promises the action will continue, and narrow market still haven't left us.

Let's look in again at the 'triple nets' as smaller-cap names show some life.

Fresh off my trip to Los Angeles, I'm psyched about what's happening in the microcap names.

These 'outliers' are suitable for income investors that value reliability, but also want to benefit from high income yields at the same time.

Let's check the charts -- and look back to the anchovy collapse of the 1970s.

Thank you, your email to has been sent successfully.

We're sorry. There was a problem trying to send your email to . Please contact customer support to let us know.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login